MFADX | NLSCX | MFADX / NLSCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 13 years | - |
Gain YTD | 4.261 | 3.966 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 1000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 96M | 7.17B | 1% |
Annual Yield % from dividends | 2.05 | 0.03 | 6,703% |
Returns for 1 year | 4.20 | 6.76 | 62% |
Returns for 3 years | 10.99 | -0.22 | -5,009% |
Returns for 5 years | 45.81 | 18.81 | 244% |
Returns for 10 years | 33.71 | 26.63 | 127% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 15.35 | N/A | N/A |
Eaton Vance Worldwide Health Sci C | |||
PWEYX | 13.21 | -0.01 | -0.08% |
PACE International Em Mkts Eq Y | |||
OSPMX | 6.33 | -0.01 | -0.16% |
Invesco SteelPath MLP Income R6 | |||
AIVIX | 15.65 | -0.05 | -0.32% |
AB International Value I | |||
FFPNX | 63.97 | -0.28 | -0.44% |
American Funds New Perspective 529-F-2 |